Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Express Scripts
Dow
McKesson
Moodys

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for ND0612


Email this page to a colleague

« Back to Dashboard

What is the drug development status for ND0612?

ND0612 is an investigational drug.

There have been 9 clinical trials for ND0612. The most recent clinical trial was a Phase 2 trial, which was initiated on August 27th 2019.

The most common disease conditions in clinical trials are Parkinson Disease and [disabled in preview]. The leading clinical trial sponsors are NeuroDerm Ltd., Michael J. Fox Foundation for Parkinson's Research, and Quotient Clinical.

There are two hundred and forty-nine US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for ND0612
TitleSponsorPhase
A Clinical Trial Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless).NeuroDerm Ltd.Phase 3
A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor FluctuationsNeuroDerm Ltd.Phase 3
A Clinical Study in Advanced Parkinson's Disease Investigating the Long Term Safety of ND0612 Administered as a Continuous SC InfusionNeuroDerm Ltd.Phase 2

See all ND0612 clinical trials

Clinical Trial Summary for ND0612

Top disease conditions for ND0612
Top clinical trial sponsors for ND0612

See all ND0612 clinical trials

US Patents for ND0612

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ND0612 ⤷  Try it Free Dopa decarboxylase inhibitor compositions NeuroDerm, Ltd. (Rehovot, IL) ⤷  Try it Free
ND0612 ⤷  Try it Free Human anti-IL-23 antibodies, compositions, methods and uses Janssen Biotech, Inc. (Horsham, PA) ⤷  Try it Free
ND0612 ⤷  Try it Free Fibronectin type III domain based scaffold compositions, methods and uses Janssen Biotech, Inc. (Horsham, PA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Express Scripts
Dow
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.